A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: guarantee (67), certify (32), warrant (16)

After evacuation of a chronic subdural haematoma - patient information

Description
This factsheet contains useful information and advice after evacuation of a chronic subdural haematoma.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/After-evacuation-of-a-chronic-subdural-haematoma-1987-PIL.pdf

AMS FLIER summary 2022 - cohort 3 applications open

Description
Future Leaders in Innovation, Enterprise and Research (FLIER) Programme The Academy of Medical Sciences is pioneering a unique p
Url
/Media/Southampton-Clinical-Research/Grants/AMS-FLIER-summary-2022-cohort-3-applications-open.pdf

Erlotinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stage IIIB or IV NS
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

Crizotinib Ver 1

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CRIZOTINIB This protocol may require funding Regimen NSCLC - Crizotinib Indication The tr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CrizotinibVer1.pdf

Gemcitabine

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEMCITABINE Regimen NSCLC - Gemcitabine Indication Second line therapy of stage III or IV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gemcitabinever12.pdf

Gefitinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEFITINIB Regimen NSCLC - Gefitinib Indication Gefitinib is recommended as an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gefitinibver13.pdf

Gemcitabine RT ver1

Description
Chemotherapy Protocol BLADDER CANCER GEMCITABINE RT Regimen Bladder – Gemcitabine RT Indication The treatment of muscle invasive bladder cancer WHO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-RT-ver1.pdf

Gemcitabine (21day) ver1.1

Description
Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic urothelial cancer in patien
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf

Fluorouracil Mitomycin RT

Description
Chemotherapy Protocol BLADDER CANCER FLUOROURACIL-MITOMYCIN-RADIOTHERAPY Regimen • Bladder Cancer – Fluorouracil-Mitomycin-Radiotherapy Indication •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Fluorouracil-Mitomycin-RT.pdf

Enzalutamide

Description
Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended within its marketing authorisat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf
821 to 830 of 1000
Previous … 81 82 83 84 85 … Next